How ‘Optimal’ are Optimal Sampling Times for Tyrosine Kinase Inhibitors in Cancer? Practical Considerations
Crossref DOI link: https://doi.org/10.1007/s40262-016-0394-3
Published Online: 2016-04-16
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ward, Michael B.
Reuter, Stephanie E.
Martin, Jennifer H.
Text and Data Mining valid from 2016-04-16